Drug Pipeline

SHR-1819 Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
2
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT07321951
A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis		 overall status: "Recruiting" → "Active Not Recruiting"
Active Studies by Phase
Phase 3
1
Phase 2/3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07309055 A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis Adolescents With Moderate-to-severe Atopic Dermatitis Recruiting
Phase 2/3
NCT06554509 Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With… Prurigo Nodularis Recruiting
Phase 2
NCT07321951 A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis Moderate-to-severe Atopic Dermatitis Active, Not Recruiting
Phase 1
NCT07264335 A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using… Atopic Dermatitis Active, Not Recruiting
Sponsors Running SHR-1819 Injection Trials
Guangdong Hengrui Pharmaceutical Co., Ltd (4)
Disease Areas
Atopic Dermatitis (3)
Get alerts when SHR-1819 Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free